Home NDC 49884-937 QUESTRAN
Product NDC 49884-937
11-digit product format 498840937
Labeler code 49884
Product ID 49884-937_ad7006dd-1ffb-4d96-878c-c502d37f7f8c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Cholestyramine
Dosage form POWDER, FOR SUSPENSION
Route ORAL
Labeler Endo USA, Inc.
Application ANDA077203
Marketing category ANDA
Marketing start 2003-07-24
Substance CHOLESTYRAMINE
Active strength 4 g/5g
Pharmacologic classes Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 48 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A077203-001 CHOLESTYRAMINE LIGHT CHOLESTYRAMINE EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 A077203-002 CHOLESTYRAMINE LIGHT CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A077203-001 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/PACKET POWDER / ORAL AB 2005-08-26 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A077203-002 CHOLESTYRAMINE LIGHT EQ 4GM RESIN/SCOOPFUL POWDER / ORAL AB 2005-08-26 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 84 observed states.
Additional Listing Data#
Finished product Yes
Brand name base QUESTRAN
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CHOLESTYRAMINE 4 g/5g
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 4B33BGI082 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 848943 Internal RxNorm lookup 848949 Internal RxNorm lookup 1801279 Internal RxNorm lookup 1801280 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 49884-937-63 QUESTRAN 5 g in 1 PACKET POWDER, FOR SUSPENSION 5 12 49884-937-65 QUESTRAN 60 in 1 CARTON POWDER, FOR SUSPENSION 60 12 49884-937-67 QUESTRAN 210 g in 1 CAN POWDER, FOR SUSPENSION 210 12
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CHOLESTYRAMINE ACTIVE INGREDIENT 4B33BGI082 QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.] 5 CHOLESTYRAMINE ACTIVE MOIETY 4B33BGI082 QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.] 5 ACACIA INACTIVE INGREDIENT 5C5403N26O QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.] 5 ANHYDROUS CITRIC ACID INACTIVE INGREDIENT XF417D3PSL QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.] 5 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.] 5 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.] 5 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.] 5 PROPYLENE GLYCOL ALGINATE INACTIVE INGREDIENT 26CD3J2R0C QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.] 5 SUCROSE INACTIVE INGREDIENT C151H8M554 QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [PAR PHARMACEUTICAL INC.] 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 49884-937 QUESTRAN (CHOLESTYRAMINE) POWDER, FOR SUSPENSION [ENDO USA, INC.] 12 Current NDC, Legacy NDC, 3 package rows 20250112_362ddd91-a63f-4ec6-841a-75785dd208c8.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 49884-937-63 49884093763 5 g in 1 PACKET 5 g Historical 49884-937-65 49884093765 60 in 1 CARTON Historical 49884-937-67 49884093767 210 g in 1 CAN (49884-937-67) 210 g 2003-07-24 0000-00-00 No No Current